[HTML][HTML] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski, Y Elamin… - Journal of translational …, 2020 - Springer
Background An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
[PDF][PDF] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
S Toomey, A Carr, MJ Mezynski, Y Elamin, S Rafee… - 2020 - repository.rcsi.com
Background: An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski, Y Elamin… - Journal of Translational …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
An increasing number of anti-cancer therapeutic agents target specific mutant proteins that …
An increasing number of anti-cancer therapeutic agents target specific mutant proteins that …
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski… - Journal of …, 2020 - search.proquest.com
Background An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
S Toomey, A Carr, MJ Mezynski, Y Elamin… - Journal of …, 2020 - europepmc.org
Background An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
[HTML][HTML] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski… - Journal of …, 2020 - … -medicine.biomedcentral.com
An increasing number of anti-cancer therapeutic agents target specific mutant proteins that
are expressed by many different tumor types. Successful use of these therapies is …
are expressed by many different tumor types. Successful use of these therapies is …
[PDF][PDF] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
S Toomey, A Carr, MJ Mezynski, Y Elamin, S Rafee… - lenus.ie
Background: An increasing number of anti‑cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
[PDF][PDF] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski, Y Elamin… - 2020 - pstorage-rcsi-9048708668.s3 …
Background: An increasing number of anti‑cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
[PDF][PDF] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski, Y Elamin, S Rafee… - 2020 - academia.edu
Background: An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …
[HTML][HTML] Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
S Toomey, A Carr, MJ Mezynski, Y Elamin… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background An increasing number of anti-cancer therapeutic agents target specific mutant
proteins that are expressed by many different tumor types. Successful use of these therapies …
proteins that are expressed by many different tumor types. Successful use of these therapies …